The Scientist

» drug development, microbiology and immunology

Most Recent

image: Biomedical Research Bill Approved in House

Biomedical Research Bill Approved in House

By | December 1, 2016

The 21st Century Cures Act could provide funds to federal research agencies for the decade and accelerate the drug approval process.

1 Comment

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Different assays lead to opposing conclusions on bacterial spores’ requirements during germination.

0 Comments

image: Low Social Status May Weaken Immune System in Monkeys

Low Social Status May Weaken Immune System in Monkeys

By | November 29, 2016

Life at the bottom of the pecking order ramps up inflammation, according to new research, an effect that appears to be reversible.

0 Comments

A new literature review finds that even if babies born via Cesarean section have long-term health risks, as a number of past studies purport, it may not be a result of the procedure itself.

0 Comments

Obesity-associated microbiome composition can persist after weight loss, affecting the exchange of metabolites between a mouse and its resident bugs, researchers report.

0 Comments

image: More than 40 New Papers on Epigenetics Published

More than 40 New Papers on Epigenetics Published

By | November 22, 2016

The International Human Epigenome Consortium presents a series of studies on how epigenetics influences immunity, cell lineage determination, and differentiation.

0 Comments

image: Bacteria Show Signs of Starvation in Space

Bacteria Show Signs of Starvation in Space

By | November 18, 2016

E. coli cultured on the International Space Station show increased expression of genes related to starvation and acid-resistance responses, researchers report.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

image: Antarctic Bacteria Latch Onto Ice with Molecular Fishing Rod

Antarctic Bacteria Latch Onto Ice with Molecular Fishing Rod

By | November 1, 2016

Researchers describe the first known bacterial adhesion molecule that binds to frozen water. 

0 Comments

Popular Now

  1. An Aging-Related Effect on the Circadian Clock
  2. Next Generation: Personalized Probiotic Skin Care
  3. ADHD Linked to Structural Differences in the Brain
  4. Opinion: Is a Clone Really Born at Age Zero?
Business Birmingham